Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.745E-09 | 2.989E-05 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 3.014E-08 | 2.188E-04 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 3.678E-07 | 8.899E-04 | BCHE, CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 8.842E-07 | 1.750E-03 | CYP2D6, CYP3A4 |
BP | GO:0023052; signaling | GO:0050805; negative regulation of synaptic transmission | 5.617E-06 | 7.644E-03 | ACHE, BCHE, DRD1 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.418E-07 | 8.899E-04 | CYP1A2, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0003990; acetylcholinesterase activity | 2.948E-07 | 8.899E-04 | ACHE, BCHE |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 1.768E-06 | 2.961E-03 | CYP1A2, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.924E-06 | 2.993E-03 | CYP1A2, CYP2D6, CYP3A4 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 4.470E-04 | 4.135E-03 | CYP1A2; CYP3A4 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.747E-03 | 1.452E-02 | CYP1A2 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.108E-04 | 1.366E-03 | CYP1A2; CYP3A4 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 5.613E-04 | 4.154E-03 | CYP1A2; CYP3A4 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 7.538E-06 | 1.394E-04 | CYP2D6; CYP1A2; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 6.357E-06 | 1.394E-04 | CYP2D6; CYP1A2; CYP3A4 |
hsa03013 | RNA transport_Homo sapiens_hsa03013 | 3.843E-03 | 1.777E-02 | SMN2; SMN1 |
hsa05204 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 8.917E-04 | 5.499E-03 | CYP1A2; CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
C00-D49: Neoplasms | Cancer | C00-C96 | HIF1A; ACHE |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | DRD1 |
E00-E89: Endocrine, nutritional and metabolic diseases | Pompe's disease | E74.02 | GAA |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Psychiatric disorder | F01-F99 | DRD1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Psychotic disorders | F20-F29 | DRD1 |